Episode 267: PREMIUM – Guidelines, blood pressure and antiplatelets
In episode 267, James and Mike finally get to the first PREMIUM podcast of 2015 – and boy is it something. We discuss a new paper put out by the Edmonton gang on who actually contributes to primary care guidelines, we talk about a new systematic review of mild hypertension treatment, and finally discuss a NEJM article on the duration of dual antiplatelets. At the end we both agree this podcast was really something.
1) Contributors to primary care guidelines
2) Effects of Blood Pressure Reduction in Mild Hypertension
A Systematic Review and Meta-analysis
3) Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents